id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-4018-0001,FDA,FDA-2024-N-4018,Medical Devices; Immunology and Microbiology Devices; Classification of the Whole Exome Sequencing Constituent Device,Rule,Final Rule,2024-09-11T04:00:00Z,2024,9,,,2024-09-11T13:13:44Z,2024-20550,0,0,09000064866e9441